Calcarea Phosphorica,magnesia Phosphorica,ferrum Phosphoricum ,natrum Phosphoricum,kali Phosphoricum
Generic Name: calcarea phosphorica ,magnesia phosphorica,ferrum phosphoricum,natrum phosphoricum,kali phosphoricum
Brand Names:
Schuessler Tissue Salts Comb 5 Nerve Tonic
Uses Temporarily relieves symptoms associated with: Stress Mild anxiety Mild neuralgic pain General debility
Overview
Uses Temporarily relieves symptoms associated with: Stress Mild anxiety Mild neuralgic pain General debility
Uses
Uses Temporarily relieves symptoms associated with: Stress Mild anxiety Mild neuralgic pain General debility
Dosage
Directions Use as directed Take 30 minutes away from food. Adults Acute dose: Spray into the mouth 4 times every 30 mins until symptoms subside, up to 8 times per day. Maintenance dose: Spray into mouth 4 times, 4 times per day.
Warnings
Warnings Ask a doctor before use if you have : Symptoms persist for more than 24 hours or worsen New symptoms occur Redness or swelling is present. If pregnant or breastfeeding , ask a health professional before use. Keep out of reach of children.
Frequently Asked Questions
What is Calcarea Phosphorica,magnesia Phosphorica,ferrum Phosphoricum ,natrum Phosphoricum,kali Phosphoricum used for?▼
Uses Temporarily relieves symptoms associated with: Stress Mild anxiety Mild neuralgic pain General debility
What are the important warnings for Calcarea Phosphorica,magnesia Phosphorica,ferrum Phosphoricum ,natrum Phosphoricum,kali Phosphoricum?▼
Warnings Ask a doctor before use if you have : Symptoms persist for more than 24 hours or worsen New symptoms occur Redness or swelling is present. If pregnant or breastfeeding , ask a health professional before use. Keep out of reach of children.
Related Medications
Ps-3866 Burn Ease, 0.9g
ps-3866 burn ease, 0.9g
Purpose Analgesic
Bevacizumab-awwb
bevacizumab-awwb
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Bevacizumab-awwb is a vascular endothelial growth factor inhibitor. Bevacizumab-awwb is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-awwb has an approximate molecular weight of 149 kDa. Bevacizumab-awwb is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Avanafil
avanafil
Phosphodiesterase 5 Inhibitor [EPC]
11 DESCRIPTION Avanafil is a selective inhibitor of cGMP-specific PDE5. Avanafil is designated chemically as (S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]- N -(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide and has the following structural formula: Avanafil occurs as an off-white to white powder, molecular formula C 23 H 26 ClN 7 O 3 and molecular weight of 483.95 and is slightly soluble in methanol, ethanol and insoluble in water.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.